Sunday, August 3, 2008

A general assessment of the safety of HMG CoA reductase inhibitors (statins)

Abstract  Few principles in medicine today are as well accepted as the benefits of using statins to reduce cardiovascular risk factors and to prevent cardiovascular disease. The recent withdrawal of a statin (cerivastatin) has lead to a

No comments: